CN Patent

CN105102000B — 使用pi3激酶亚型调节剂的癌症疗法

Assigned to Infinity Pharmaceuticals Inc · Expires 2021-10-22 · 5y expired

What this patent protects

本文提供了用于治疗癌症或血液病的包括PI3激酶抑制剂的方法、药盒和药物组合物。

USPTO Abstract

本文提供了用于治疗癌症或血液病的包括PI3激酶抑制剂的方法、药盒和药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN105102000B
Jurisdiction
CN
Classification
—
Expires
2021-10-22
Drug substance claim
No
Drug product claim
No
Assignee
Infinity Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.